Global IBP & Analytics Leader for Rare Disease

BioMarin Pharmaceutical Inc.; Ireland; Hybrid; EUR 150,000 - 210,000; Full time

Job summary

BioMarin Pharmaceutical Inc. is seeking a Senior Director of Integrated Planning & Analytics to lead enterprise IBP across demand, supply, inventory, capacity, and financial objectives for a rare-disease network.

You will connect Commercial, Clinical, Manufacturing, Quality, Regulatory, Medical, and Finance decisions to ensure patient access and growth. The role focuses on long-range capacity planning, risk management, and building planning capabilities with a 24–60 month horizon, in a hybrid

Qualifications

• Bachelor’s degree in Supply Chain, Engineering, Business, Life Sciences, or related field.
• 12+ years of progressive supply chain or operations leadership in biotech, pharmaceutical, or rare disease environments.
• Proven leadership of global S&OP/IBP processes, including long-range capacity planning, inventory strategy, and executive decision support.

Responsibilities

• Own the global IBP framework for rare disease planning, addressing demand variability, small batches, long lead times, and constrained capacity.
• Establish and maintain a consistent IBP cadence (Product Review, Demand Review, Supply Review, Integrated Reconciliation, Executive IBP).
• Own the S&O E (Sales & Operations Execution) process, ensuring near-term demand, supply, and inventory decisions are aligned to the broader IBP framework and escalated appropriately.
• Embed patient-centric planning principles into the IBP cycle (e.g., emergency orders, compassionate use, urgent clinical supply requests).
• Ensure seamless integration of clinical and commercial planning due to overlapping supply sources and shared manufacturing assets.
• Oversee reconciliation of commercial, patient, named-patient, early-access, and clinical trial demand signals.
• Ensure supply plans reflect long cycle times, yield variability, cold-chain requirements, and CMO dependencies.
• Lead Inventory Management to define inventory policies, targets, and positioning strategies that minimize expiry while guaranteeing immediate patient access for ultra-low-volume therapies.
• Lead risk-based scenario planning for demand surges (e.g., new diagnoses, outbreaks, compassionate use clusters), supply disruptions, or single-source component issues.
• Chair IBP forums across Commercial, Clinical Operations, Technical Operations, Manufacturing, Quality, Regulatory, Finance, and Medical.
• Establish governance and decision rights for trade-offs such as allocation priorities, safety stock strategies, and launch readiness.
• Lead structured decision-making in Executive IBP, ensuring senior leaders have clear scenarios, risks, and recommendations.
• Drive alignment across global, regional, and country planning, accounting for reimbursement and access variability.
• Lead the team of Integrating Planning & Analytics professionals, through strong development and mentoring while creating a culture of high accountability and innovation.
• Ensure there are departmental performance goals and objectives that the team of integrated planners can leverage to develop their respective objectives and provide performance feedback related to business objectives.
• Create a training curriculum to support Integrated Planning & Analytics Team’s development responsibilities.
• Influence teams across the supply chain planning organization to improve their maturity and collaboration through a harmonized integrated planning playbook maximizing optimal support to the planning cycles.
• Partner closely with Finance, particularly during AOP/LRP cycles, to embed operational, revenue, COGS, and margin considerations into IBP.
• Integrate portfolio plans including new indications, lifecycle extensions, label expansions, and transitions from clinical supply platforms to scaled commercial supply.
• Support business case development for strategic investments (redundant capacity, alternate sites, new technology platforms) and lead long-range capacity planning/modelling to ensure the network can support future portfolio growth, new indications, and evolving patient demand.
• Leading and enhancing performance management and visualization efforts, specifically improving dashboards that can be used across markets, supply, finance, and overall performance management
• Define the IBP technology vision with Digital/IT, including platforms for complex, low-volume, high-variability planning.
• Ensure data quality for critical demand, therapy, batch, expiry, and distribution attributes.
• Lead Data Analytics to develop advanced planning insights, improve forecast ability of ultra-small populations, and evaluate risk-based scenarios for proactive decision-making.
• Drive adoption of IBP behaviours in a highly cross-functional, mission-driven rare disease culture.
• Communicate clearly with senior leadership on risks, trade-offs, and opportunities, always emphasizing patient impact.
• Build planning capability across global and regional teams and mentor planners supporting rare disease products.
• Function as an internal expert and thought leader on best-practice IBP/S&OP for rare disease and biologics.
• KPI & Metrics include: Patient & Service Metrics, Supply Reliability Metrics, Inventory & Waste Metrics, Forecast & Financial Metrics, IBP Process Health Metrics.

Skills

Leadership

Global/Matrix leadership

Cross-functional collaboration

Education

Bachelor’s degree in Supply Chain, Engineering, Business, Life Sciences, or related field

Tools

ERP systems

Advanced planning systems

Analytics tools

Job description

BioMarin Pharmaceutical Inc. is seeking a Senior Director of Integrated Planning & Analytics to lead enterprise IBP across demand, supply, inventory, capacity, and financial objectives for a rare-disease network.

You will connect Commercial, Clinical, Manufacturing, Quality, Regulatory, Medical, and Finance decisions to ensure patient access and growth. The role focuses on long-range capacity planning, risk management, and building planning capabilities with a 24–60 month horizon, in a hybrid